A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors With PTCH1 Loss-of-function Mutations
Interventions: DRUG: ENV-101 (taladegib)
Sponsor: Endeavor Biomedicines, Inc.